Calif. Lawmakers: Immediate Investigation Into Purdue Pharma’s Opioid Practices Necessary

August 30, 2016
In The News

“There appears to be a pervasive disregard for patient safety and public health by some within the pharmaceutical industry," Rep. Mark DeSaulnier and Rep. Ted Lieu said in calling for the House Oversight and Government Reform Committee to take action against the drugmaker.

Two California representatives called Monday for a congressional investigation of opioid manufacturers, citing a Los Angeles Times investigation that found that the maker of OxyContin collected extensive evidence of criminal trafficking of its drug but in many cases did not alert law enforcement. Rep. Mark DeSaulnier (D-Concord) and Rep. Ted Lieu (D-Torrance), both members of the House Oversight and Government Reform Committee, said in a letter to the committee chairs that an immediate investigation was necessary “to fully understand the implications and consequences of pharmaceutical companies that do not fulfill their legal and ethical requirements to restrict the sale of opioids in circumstances that raise suspicion regarding inappropriate prescribing practices.” (Ryan, 8/29)